0000000000-24-007602.txt : 20240827 0000000000-24-007602.hdr.sgml : 20240827 20240703143611 ACCESSION NUMBER: 0000000000-24-007602 CONFORMED SUBMISSION TYPE: UPLOAD PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20240703 FILED FOR: COMPANY DATA: COMPANY CONFORMED NAME: ARCA biopharma, Inc. CENTRAL INDEX KEY: 0000907654 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 363855489 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: UPLOAD SEC FILE NUMBER: 333-279387 BUSINESS ADDRESS: STREET 1: 10170 CHURCH RANCH WAY STREET 2: SUITE 100 CITY: WESTMINSTER STATE: CO ZIP: 80021 BUSINESS PHONE: 7209402200 MAIL ADDRESS: STREET 1: 10170 CHURCH RANCH WAY STREET 2: SUITE 100 CITY: WESTMINSTER STATE: CO ZIP: 80021 FORMER COMPANY: FORMER CONFORMED NAME: NUVELO INC DATE OF NAME CHANGE: 20030203 FORMER COMPANY: FORMER CONFORMED NAME: HYSEQ INC DATE OF NAME CHANGE: 19970610 PUBLIC REFERENCE ACCESSION NUMBER: 0001213900-24-042529 LETTER 1 filename1.pdf begin 644 filename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end TEXT-EXTRACT 2 filename2.txt July 3, 2024 Thomas A. Keuer President and Chief Operating Officer ARCA biopharma, Inc. 10170 Church Ranch Way, Suite 100 Westminster, CO 80021 Re: ARCA biopharma, Inc. Amendment No. 1 to Registration Statement on Form S-4 Filed June 18, 2024 File No. 333-279387 Dear Thomas A. Keuer: We have reviewed your amended registration statement and have the following comments. Please respond to this letter by amending your registration statement and providing the requested information. If you do not believe a comment applies to your facts and circumstances or do not believe an amendment is appropriate, please tell us why in your response. After reviewing any amendment to your registration statement and the information you provide in response to this letter, we may have additional comments. Unless we note otherwise, any references to prior comments are to comments in our June 11, 2024 letter. Amendment No. 1 to Registration Statement on Form S-4 Oruka's Pipeline, page 214 1. We note your response to prior comment 11 and your revised disclosure on page 214. We note that the pipeline table does not provide an indication for ORKA-003 or "Combinations." Given the status of development and limited disclosure regarding the programs for ORKA-003 and "Combinations," it does not appear appropriate to highlight these programs in your pipeline table. If these programs are material to your business to warrant inclusion in your pipeline table, please expand your disclosure in your Business section to provide a more fulsome discussion of these programs, including descriptions of preclinical studies or other development activities conducted. Alternatively, please remove these programs from the pipeline table or advise. 2. Please revise your pipeline table to include columns of equal width for each of Phase 1, Phase 2 and Phase 3 of clinical testing. July 3, 2024 Page 2 Please contact Jenn Do at 202-551-3743 or Kevin Kuhar at 202-551-3662 if you have questions regarding comments on the financial statements and related matters. Please contact Tamika Sheppard at 202-551-8346 or Joshua Gorsky at 202-551-7836 with any other questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Brent D. Fassett